Browsing: Eisai Co Ltd

The Food and Drug Administration on Thursday authorized the Alzheimer’s therapy Leqembi, a pivotal determination that’s anticipated to develop entry…

The Alzheimer’s drug LEQEMBI is seen on this undated handout picture obtained by Reuters on January 20, 2023.Eisai | by…

Juanmonino | E+ | Getty ImagesSeniors with early Alzheimer’s illness will face main hurdles to get handled even when promising…